MIRA Pharmaceuticals, Inc. Common Stock (MIRA)
MIRA Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for neurological and psychiatric disorders. The company aims to address unmet medical needs through its research-driven pipeline, utilizing novel drug delivery systems and targeted treatments.
Company News
Mira Pharmaceuticals saw significant after-hours stock price increase following preclinical data announcement for Mira-55, a non-psychotropic marijuana compound that demonstrated superior pain reduction compared to morphine in animal studies.
Over 50 companies are advancing cannabinoid drug research, exploring potential treatments for mental health disorders, neurodegenerative diseases, and chronic inflammation, with promising clinical trials targeting conditions like Alzheimer's, pain management, and epilepsy.
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week